Exact Mass: 406.221609
Exact Mass Matches: 406.221609
Found 500 metabolites which its exact mass value is equals to given mass value 406.221609
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lincomycin
C18H34N2O6S (406.21374640000005)
Lincomycin is only found in individuals that have used or taken this drug. It is an antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. [PubChem]Lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50 S subunits of bacterial ribosomes and preventing peptide bond formation upon transcription. It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Flurogestone Acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone Same as: D04235
Kiwiionoside
Kiwiionoside is found in fruits. Kiwiionoside is a constituent of Actinidia chinensis (kiwifruit). Constituent of Actinidia chinensis (kiwifruit). Kiwiionoside is found in fruits.
Annoglabasin C
Annoglabasin C is found in alcoholic beverages. Annoglabasin C is a constituent of Annona glabra (pond apple) Constituent of Annona glabra (pond apple). Annoglabasin C is found in alcoholic beverages and fruits.
(1R,3R,4R,5S,6S,8x)-1-Acetoxy-8-angeloyloxy-3,4-epoxy-5-hydroxy-7(14),10-bisaboladien-2-one
(1R,3R,4R,5S,6S,8x)-1-Acetoxy-8-angeloyloxy-3,4-epoxy-5-hydroxy-7(14),10-bisaboladien-2-one is found in tea. (1R,3R,4R,5S,6S,8x)-1-Acetoxy-8-angeloyloxy-3,4-epoxy-5-hydroxy-7(14),10-bisaboladien-2-one is a constituent of flower buds of Tussilago farfara (coltsfoot). Constituent of flower buds of Tussilago farfara (coltsfoot). (1R,3R,4R,5S,6S,8x)-1-Acetoxy-8-angeloyloxy-3,4-epoxy-5-hydroxy-7(14),10-bisaboladien-2-one is found in tea.
1-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol
1-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol is found in herbs and spices. 1-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol is a constituent of the dried rhizomes of Zingiber officinale (ginger). Constituent of the dried rhizomes of Zingiber officinale (ginger). 1-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol is found in herbs and spices.
13-Acetylphorbol
Argentine
Epilincomycin
C18H34N2O6S (406.21374640000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Fluorogestone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins
Panduratin A
Pravastatin lactone
Adenosine, 8-(butylamino)-N-cyclopentyl-
Xanthoangelol F
Xanthoangelol f is a member of the class of compounds known as 3-prenylated chalcones. 3-prenylated chalcones are chalcones featuring a C5-isoprenoid unit at the 3-position. Thus, xanthoangelol f is considered to be a flavonoid lipid molecule. Xanthoangelol f is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Xanthoangelol f can be found in angelica, which makes xanthoangelol f a potential biomarker for the consumption of this food product.
2,6-Dihydroxy-3-(1-p-menthen-3-yl)-4-methoxychalcone
Heminitidulan
Methyl ent-16-acetoxy-6alpha-hydroxy-17-oxo-7,13E-labdadien-15-oate
[1S-[1alpha(E),3(E),5beta,6alpha]]-5-(acetyloxy)-6-(1-methylethyl)-3-[[(2-methyl-1-oxo-2-butenyl)oxy]methyl]-4-oxo-2-cyclohexen-1-yl ester
Methyl ent-16-acetoxy-8beta-formyl-8-desmethyl-6,13E-labdadien-15-oate
(17alpha)-3,5,14,19-tetrahydroxycard-20(22)-enolide
15-O-Isovaleroyl-3beta-O-acetyl-2alpha-hydroxyamphoricarpolide
Methyl ent-16-acetoxy-6beta-hydroxy-17-oxo-7,13E-labdadien-15-oate
Lophanthoidin E
Adunctin C
N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide
C21H28F2N4O2 (406.21802119999995)
11alpha-Acetoxy-3beta,12beta,14-trihydroxy-14beta-pregn-5-en-20-on|11alpha-acetoxy-3beta,12beta,14-trihydroxy-14beta-pregn-5-en-20-one|Drevogenin B; 11-O-Acetyl-drevogenin P
1(10)E-3Z-(5R,7S,8S)-14-acetyloxy-5-hydroxy-15-isovaleroyloxygermacra-1(10),3,11(13)-trien-8,12-olide
methyl-1alpha-acetoxy-7alpha,14alpha-dihydroxy-8,15-isopimaradien-18-oate
2beta-acetoxy-19-carboxymethyl-cleroda-3,13-dien-15-oic acid
5-[(1R*,2S*,3R*)-1-hydroxy-4-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dimethylbutyl]-2,3-dimethoxyphenol|kadsuphilin J
(+)-7beta-acetoxy-16-hydroxy-3,13-clerodadien-16,15-olid-18-oic acid
15-O-isovaleroyl-3beta-O-acetyl-9beta-hydroxyamphoricarpolide|15-O-Isovaleroyl-3??-O-acetyl-9??-hydroxyamphoricarpolide
(1aR,3S,4R,4aS,5S,8aS,9aS)-8a-ethoxy-2,3,4,4a,5,7,8a,9-octahydro-5-hydroxy-4,4a,6-trimethyl-7-oxo-1aH-oxireno[2,3:8,8a]naphtho[2,3-b]furan-3-yl (E)-2-methylbut-2-enoate|(1beta,3beta,6beta,8beta,10beta)-3-(angeloyloxy)-1,10-epoxy-8-ethoxy-6-hydroxyeremophil-7(11)-en-8,12alpha-olide
(7S,8R,8aR)-7-(acetyloxy)-3,5,6,7,8,8a-hexahydro-alpha,8,8a-trimethyl-alpha-(2-methyl-1-oxobutoxy)-3-oxonaphthalene-2-acetic acid|3beta-(acetyloxy)-11-(2-methylbutanoyloxy)-8-oxoeremophila-6,9-dien-12-oic acid
9beta-hydroxyovatifolin-8-O-(2-methylbutyrate)|9beta-hydroxyovatifolin-8-O-<2-methylbutyrate>
(4S,4aS,5S,8aR,9aR)-9a-ethoxy-2,4,4a,5,6,7,8,8a,9,9a-decahydro-3,4a-dimethyl-4-{[(2Z)-2-methylbut-2-enoyl]oxy}-2-oxonaphtho[2,3-b]furan-5-carboxylic acid|6beta-(angeloyloxy)-8alpha-ethoxyeremophil-7(11)-ene-8beta,12-olide-15beta-oic acid
(+/-)-isopanduratin A1|4-(2,4-Dihydroxy-6-methoxybenzoyl)-1-methyl-5-phenyl-6-prenylcyclohexene
9alpha-acetyloxy-14-hydroxy-8beta-(2-methylbutanoyloxy)acanthospermolide
8alpha-(isovaleryloxy)-8-desacylviguestenin|8alpha--8-desacylviguestenin
methyl 14alpha-acetoxy-7alpha,11alpha-dihydroxy-8,15-isopimaradien-18-oate
methyl 3alpha-acetoxy-13xi,14xi-epoxy-15-oxo-labd-8(17)-en-19-oate
methyl 7alpha-acetoxy-8beta,14beta-diformylpodocarpane-13beta-carboxylate
19-O-acetyl-3beta,12beta,14beta,19-tetrahydroxypregn-5-en-20-one|sakuragenin
5-|A-PREGNAN-3-|A, 17,21-TRIOL-11,20-DIONE 3-ACETATE
(20S*)-14beta-acetoxy-1alpha,15beta-dihydroxy-20-methoxy-7alpha,20-epoxy-ent-kaur-16-ene|rubluanin A
3beta,5alpha,14beta,17beta-tetrahydroxycard-20(22)-enolide
6-[10-(12,12-dimethyl-13alpha-(22-methyl-21-butenoyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone N
6-[10-(12,12-dimethyl-13alpha-(tigloyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone O
lespeflorin G5
A member of the class of pterocarpans that is (6aR,11aR)-pterocarpan substituted by hydroxy groups at positions 3 and 9, a methyl group at position 8 and prenyl groups at positions 4 and 10. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
dimethyl (2E,6E,10Z,14Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10,14-tetraenedioate
Ajugarin IV|ajugarin-IV|Me ester,Ac-6-Hydroxy-13-cleroden-15,16-olid-18-oic acid
COc1ccc(C(=O)C=Cc2ccc(O)cc2)c(O)c1CC=C(/C)CCC=C(C)C
methyl 7alpha-acetoxy-11alpha,14alpha-dihydroxy-8,15-isopimaradien-18-oate
methyl ent-8(R),15(S)epoxy-12beta-acetoxy-16-hydroxypimar-9(11)-en-19-oate
5-Oxo,6-hydroxy,6-Me ether-(R)-3,4-Dihydro-6,8-dihydroxy-3-tridecyl-1H-2-benzopyran-1-one
3,5,6-trihydroxydehydro-alpha-ionol 9-O-beta-D-glucopyranoside
Bipindogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Lincomycin
C18H34N2O6S (406.21374640000005)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides A carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Pyrrolidines CONFIDENCE standard compound; INTERNAL_ID 1180 CONFIDENCE standard compound; INTERNAL_ID 4105 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3687
Lincomycin aka '(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
C19H34O9_beta-D-Glucopyranoside, 3,6-dihydroxy-3-[(1E)-3-hydroxy-1-buten-1-yl]-2,4,4-trimethylcyclohexyl
C19H34O9_2,4-Dihydroxy-4-[(1E)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethylcyclohexyl beta-D-glucopyranoside
Ala Ala Phe Val
Ala Ala Val Phe
Ala Phe Ala Val
Ala Phe Gly Ile
Ala Phe Gly Leu
Ala Phe Ile Gly
Ala Phe Leu Gly
Ala Phe Val Ala
Ala Gly Phe Ile
Ala Gly Phe Leu
Ala Gly Ile Phe
Ala Gly Leu Phe
Ala Ile Phe Gly
Ala Ile Gly Phe
Ala Leu Phe Gly
Ala Leu Gly Phe
Ala Val Ala Phe
Ala Val Phe Ala
Phe Ala Ala Val
Phe Ala Gly Ile
Phe Ala Gly Leu
Phe Ala Ile Gly
Phe Ala Leu Gly
Phe Ala Val Ala
Phe Gly Ala Ile
Phe Gly Ala Leu
Phe Gly Ile Ala
Phe Gly Leu Ala
Phe Ile Ala Gly
Phe Ile Gly Ala
Phe Leu Ala Gly
Phe Leu Gly Ala
Phe Val Ala Ala
Gly Ala Phe Ile
Gly Ala Phe Leu
Gly Ala Ile Phe
Gly Ala Leu Phe
Gly Phe Ala Ile
Gly Phe Ala Leu
Gly Phe Ile Ala
Gly Phe Leu Ala
Gly Ile Ala Phe
Gly Ile Phe Ala
Gly Leu Ala Phe
Gly Leu Phe Ala
Ile Ala Phe Gly
Ile Ala Gly Phe
Ile Phe Ala Gly
Ile Phe Gly Ala
Ile Gly Ala Phe
Ile Gly Phe Ala
Ile Ser Ser Thr
Ile Ser Thr Ser
Ile Thr Ser Ser
Leu Ala Phe Gly
Leu Ala Gly Phe
Leu Phe Ala Gly
Leu Phe Gly Ala
Leu Gly Ala Phe
Leu Gly Phe Ala
Leu Ser Ser Thr
Leu Ser Thr Ser
Leu Thr Ser Ser
Pro Pro Pro Pro
Ser Ile Ser Thr
Ser Ile Thr Ser
Ser Leu Ser Thr
Ser Leu Thr Ser
Ser Ser Ile Thr
Ser Ser Leu Thr
Ser Ser Thr Ile
Ser Ser Thr Leu
Ser Thr Ile Ser
Ser Thr Leu Ser
Ser Thr Ser Ile
Ser Thr Ser Leu
Ser Thr Thr Val
Ser Thr Val Thr
Ser Val Thr Thr
Thr Ile Ser Ser
Thr Leu Ser Ser
Thr Ser Ile Ser
Thr Ser Leu Ser
Thr Ser Ser Ile
Thr Ser Ser Leu
Thr Ser Thr Val
Thr Ser Val Thr
Thr Thr Ser Val
Thr Thr Val Ser
Thr Val Ser Thr
Thr Val Thr Ser
Val Ala Ala Phe
Val Ala Phe Ala
Val Phe Ala Ala
Val Ser Thr Thr
Val Thr Ser Thr
Val Thr Thr Ser
Annoglabasin C
Kiwiionoside
CEHC glutamine
Calcium bis[(3Z)-2,2,6,6-tetramethyl-5-oxo-3-hepten-3-olate]
C22H38CaO4 (406.23958580000004)
3-N-BOC-AMINO-3-(3-CBZ)PIPERIDINE-PROPIONICACIDETHYLESTER
calcium undecylenate
C22H38CaO4 (406.23958580000004)
C254 - Anti-Infective Agent > C514 - Antifungal Agent
Verucerfont
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal
N-[(2-Cyano[1,1-biphenyl]-4-yl)methyl]-N-(1-oxopentyl)-L-valine methyl ester
Card-20(22)-enolide,3,5,14,19-tetrahydroxy-, (3b,5b)-
1-N,4-N-bis(3,5-dimethylphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
BMS-582949
1,2-bis(ethenyl)benzene,4-butoxy-4-oxobut-2-enoic acid,styrene
bis(2,2,6,6-tetramethyl-3,5-heptanedionato)calcium(ii)
C22H38CaO4 (406.23958580000004)
1-N,4-N-diphenyl-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
3,6-diethyl-1-N,4-N-bis(3-methylphenyl)-1,2,4,5-tetrazine-1,4-dicarboxamide
Tosedostat
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D004791 - Enzyme Inhibitors
Samotolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C192218 - DNA-dependent Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor Samotolisib (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. Samotolisib potently inhibits mTORC1/2 at low nanomolar concentrations[1][2]. Samotolisib (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. Samotolisib potently inhibits mTORC1/2 at low nanomolar concentrations[1][2].
[4-R-(4-alpha,6-beta,7-beta]-Hexahydro-5,6-DI(hydroxy)-1,3-DI(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone
3-Methyl-2-[[4-methyl-2-[(2,3,4,5-tetrahydroxyoxan-2-yl)methylamino]pentanoyl]amino]pentanoic acid
Panduratin A
(2S,4R)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
1-Palmitoylglycerone 3-phosphate(2-)
C19H35O7P-2 (406.21202900000003)
[(1S,3R,7S,8S,8aR)-3-hydroxy-8-[2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
a 1-Hexadec-9-enoyl-sn-glycerol 3-phosphate
C19H35O7P-2 (406.21202900000003)
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
C18H34N2O6S (406.21374640000005)
11-(2-methylpropyl)-3-[2-(morpholin-4-yl)ethyl]-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
2-(hydroxymethyl)-6-[(E)-4-(1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-yl]oxyoxane-3,4,5-triol
(2R*,3R*)-3-{[(2S)-1-({4-[(3-aminopropyl)amino]butyl}amino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
(2R*,3R*)-3-{[(2S)-1-({3-[(4-aminobutyl)amino]propyl}amino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
1-Palmitoleoyl-sn-glycerol 3-phosphate(2-)
C19H35O7P-2 (406.21202900000003)
1-[4-(2-Fluorophenyl)-1-piperazinyl]-4-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)-1-butanone
8-[11-(4-Methoxyphenyl)-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane
(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid
5-Fluoro-1-[1-[[1-(2-phenylethyl)-5-tetrazolyl]methyl]-4-piperidinyl]benzotriazole
C21H23FN8 (406.20296099999996)
4-(4-hydroxy-2,6-dimethylheptan-4-yl)-N,N-diphenyl-1-triazolecarboxamide
C24H30N4O2 (406.23686399999997)
(E)-1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
1-(2-fluorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
2-[(3R,6aR,8R,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
1-(2-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
2-[(3R,6aR,8S,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
1-(2-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
N-[2-[(2S,5R,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
(5R,8S)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
2-[(3S,6aR,8R,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3S,6aR,8S,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
[(1R)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C24H30N4O2 (406.23686399999997)
1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
N-[2-[(2R,5S,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5S,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
2-[(3S,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8R,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3S,6aS,8R,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone
[(1S)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C24H30N4O2 (406.23686399999997)
3-(4-Carboxybutanamido)-1-{4-[(2-hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
(2-hydroxy-3-phosphonooxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
C19H35O7P (406.21202900000003)
(2R,4S)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
[1-Deuterio-7-[dimethyl(trimethylsilyl)silyl]-3-[hydroxy(dimethyl)silyl]-1,2-dihydronaphthalen-2-yl]-trimethylsilane
5-Deuterio-6-hydro-7-(hydroxydimethylsilyl)-3-(pentamethyldisilanyl)-6-(trimethylsilyl)naphthalene
TMC-52D
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52D acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 280 nM, 6 nM, and 49 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
TMC-52C
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52C acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 460 nM, 10 nM, and 88 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
1-Palmitoleoyl-sn-glycerol 3-phosphate(2-)
C19H35O7P (406.21202900000003)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmitoleoyl-sn-glycerol 3-phosphate
2-16:1-lysophosphatidate(2-)
C19H35O7P (406.21202900000003)
A 2-acyl-sn-glycero-3-phosphate(2-) in which the acyl group is hexadecenoyl (position of double bond not specified).
1-Palmitoylglycerone 3-phosphate(2-)
C19H35O7P (406.21202900000003)
An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1-palmitoylglycerone 3-phosphate; major species at pH 7.3.
TG(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
3-{[1-({4-[(3-aminopropyl)amino]butyl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
methyl 9-(acetyloxy)-7-ethenyl-5,8-dihydroxy-1,4a,7-trimethyl-3,4,5,6,8,9,10,10a-octahydro-2h-phenanthrene-1-carboxylate
(2s,4r)-n-[(1s)-2-hydroxy-1-[(3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C18H34N2O6S (406.21374640000005)
methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(acetyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[8,8a-c]furan-7-carboxylate
1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
7-[2-(but-2-en-2-yl)-5-chloro-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-4-methylhepta-4,6-dien-3-one
C24H35ClO3 (406.22745900000007)
(1s,3as,3br,7s,9ar,9bs,10s,11s,11as)-1-acetyl-3a,7,11-trihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-10-yl acetate
(1s,2s,3s,6r,7s,10r,11s,12r)-2-[5-(2h-1,3-benzodioxol-5-yl)pentyl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylic acid
methyl (1s,4s,5r,9s)-4-[1-(acetyloxy)-4-(3,3-dimethyloxiran-2-yl)but-2-en-2-yl]-1-methyl-6-methylidene-10-oxabicyclo[7.1.0]decane-5-carboxylate
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2s,3e)-4-[(1r,2r,4r)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
13-methyl-4,15-bis(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
(2s)-5-hydroxy-6-[(1r,6r)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r,3e)-4-[(1s,2s,4s)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
2-({4-[3,5-dihydroxy-2-(hydroxymethyl)-2,6-dimethylcyclohexyl]but-3-en-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (3r)-5-[(1r,2s,3s,4as,8ar)-3-(acetyloxy)-7-hydroxy-1,2,4a-trimethyl-5-methylidene-6-oxo-2,3,4,8a-tetrahydronaphthalen-1-yl]-3-methylpentanoate
6-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
5-methoxy-2-[(3r,8r)-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]phenol
5-methoxy-2-[(3s,8r)-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]phenol
(2r)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r)-4-[(1s,2r,3r,4s)-2,3,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
6-(8-hydroxy-5,9-dimethoxy-7-methyltetradeca-1,3,9,11-tetraen-1-yl)-5-methoxy-5,6-dihydropyran-2-one
methyl 3-[(acetyloxy)methyl]-5-[2-(formyloxy)-5,5,8a-trimethyl-1,2,4a,6,7,8-hexahydronaphthalen-1-yl]pent-2-enoate
5-methoxy-2-[(1s,6s)-4-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol
(4bs,6as,10as,10bs)-4b,7,7,10a-tetramethyl-2-(2-sulfoethyl)-4ah,5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-4a-yl
C23H36NO3S (406.24157660000003)